Lendway Changes Name to Bloomia Holdings, Stock Symbol TULP
Lendway announced that it will change its corporate name to Bloomia Holdings. The name change is expected to be effective on or around February 2 on the Nasdaq Capital Market. Concurrent with the corporate name change, the company's common stock will begin trading under the symbol "TULP" on the Nasdaq. Lendway's Chairman and Co-Chief Executive Officer, Mark Jundt, commented, "Our tulip business, under the name Bloomia, is our prized asset and primary focus of the company. Changing the company's name reflects our focus, commitment and enthusiasm for the future of Bloomia." Co-Chief Executive Officer Dan Philp added, "In addition to the name change, we chose the ticker symbol TULP because it is the Dutch word for tulip and aligns with our new focus. The ticker symbol 'TULP' reflects many important aspects of our business."
Trade with 70% Backtested Accuracy
Analyst Views on LDWY
About LDWY
About the author

- Corporate Name Change: Lendway, Inc. announced it will change its name to Bloomia Holdings, Inc. effective February 2, 2026, aligning its corporate identity with current operations and long-term growth objectives, reflecting commitment and enthusiasm for future development.
- Ticker Symbol Change: Following the name change, the company's stock will trade under the new symbol TULP on NASDAQ, which is the Dutch word for tulip, symbolizing the company's focus on its core business and expected to enhance market recognition.
- Management Commentary: Co-CEO Mark Jundt stated that the tulip business is the company's prized asset, and the name change reflects a commitment to Bloomia's future, demonstrating confidence in the company's growth trajectory.
- Industry Position: Bloomia Holdings, Inc. is one of the largest producers of fresh-cut tulips in the United States, focusing on agricultural investments, and the rebranding is expected to further solidify its leadership position in the industry.
Stock Performance: Lendway Inc. (NASDAQ: LDWY) saw a 19.88% increase in after-hours trading, reaching $4.10, despite closing down 3.11% at $3.42 during regular trading. The stock is down 26.92% year-to-date.
Certificate of Amendment: The company filed a Certificate of Amendment in Delaware, increasing its authorized common stock from 5.71 million to 10 million shares, effective immediately.
Shareholder Approval: The proposal to increase authorized shares received 1.17 million votes in favor, with 223,490 against and 5,241 abstentions, following resolutions passed by the Board on September 26.
Annual Meeting Outcomes: During the Annual Meeting, six nominees were elected as directors for a one-year term, with CFO Elizabeth E. McShane signing the filing related to the stock amendment.
Insignia Financial Update: Australian wealth manager Insignia Financial announced that CC Capital Partners is still preparing a binding offer, nearly four months after gaining access to the company's financials.
Bain Capital Withdrawal: While CC Capital continues its efforts, rival bidder Bain Capital withdrew from the process two months after initially being granted access in March.
Bain Capital's Offer: Bain Capital has increased its offer for Insignia Financial to approximately US$2.12 billion, allowing them access to the company's financial records for due diligence.
Rival Bidder: Insignia Financial will also permit due diligence for CC Capital Partners, as both bidders have raised their cash proposals to 5.00 Australian dollars per share, roughly equivalent to US$3.17.
Brookfield's Proposal: Brookfield Asset Management has made a US$1.93 billion non-binding proposal for Insignia Financial, offering 4.60 Australian dollars (US$2.88) per share.
Competitive Bidding: This proposal marks the third interest in Insignia, matching previous offers from CC Capital Partners and Bain Capital.
Takeover Proposal Update: Insignia Financial announced that CC Capital Partners has improved its takeover offer for the company, surpassing the bid from Bain Capital.
Revised Offer Details: The new proposal from CC Capital is valued at 4.60 Australian dollars (approximately US$2.86) per share.











